Industry › BioTech

Press Releases

バイオジェンとエーザイはアルツハイマー病治療薬の提携契約を変更

Mar 16, 2022 10:00 JST

Eisai: Economic Arrangements of Amendment to Alzheimer's Disease Treatment Collaboration Agreement with Biogen

Mar 15, 2022 12:03 HKT/SGT

Biogen and Eisai Amend Collaboration Agreements on Alzheimer's Disease Treatments

Mar 15, 2022 11:00 HKT/SGT

中国抗体用于哮喘的第一类治疗产品SM17新药研究申请获FDA批准

Mar 14, 2022 20:34 HKT/SGT

中國抗體用於哮喘的第一類治療產品SM17新藥研究申請獲FDA批准

Mar 14, 2022 20:33 HKT/SGT

IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Approved by FDA

Mar 14, 2022 20:32 HKT/SGT

雅各臣獲主席增持股份至超過六成

Mar 14, 2022 19:59 HKT/SGT

Jacobson Pharma's Chairman Uplifts Shareholding to Above 60%

Mar 14, 2022 19:58 HKT/SGT

Eisai to Present New Lecanemab Data Exploring Distinct Mechanism of Action and Clinical Outcomes, Disease State (DSE) Symposium, and Other Pipeline Assets at the AD/PD 2022 Annual Meeting

Mar 11, 2022 11:15 HKT/SGT

金活醫藥建設龍德健康產業園10月底竣工

Mar 11, 2022 08:22 HKT/SGT

医思健康推出遥距医疗及药物配送服务减少外出感染风险守护市民健康

Mar 09, 2022 15:17 HKT/SGT

醫思健康推出遙距醫療及藥物配送服務減少外出感染風險守護市民健康

Mar 09, 2022 15:16 HKT/SGT

EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen's Health

Mar 09, 2022 15:15 HKT/SGT

医思健康主席邓志辉进一步增持公司股份对集团发展前景充满信心

Mar 09, 2022 09:41 HKT/SGT

醫思健康主席鄧志輝進一步增持公司股份對集團發展前景充滿信心

Mar 09, 2022 09:40 HKT/SGT

EC Healthcare's Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group's Future Development

Mar 09, 2022 09:39 HKT/SGT

NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets

Mar 09, 2022 08:05 HKT/SGT

LENVIMA in Combination with KEYTRUDA Approved In Taiwan for the Treatment of Patients with Advanced Endometrial Carcinoma

Mar 07, 2022 12:50 HKT/SGT

医思健康获纳入深港通之合资格股份

Mar 07, 2022 12:47 HKT/SGT

醫思健康獲納入深港通之合資格股份

Mar 07, 2022 12:46 HKT/SGT